title: The prenylation inhibitor, lonafarnib: a new therapeutic strategy against hepatitis delta.
authors.affiliation: Department of Medicine, University of Turin, Corso Bramante 88, Turin 10126, Italy. Electronic address: mrizzetto@cittadellasalute.to.it.
authors.forename: Mario
authors.initials: M
authors.lastname: Rizzetto
authors.affiliation: Department of Medicine, University of Turin, Corso Bramante 88, Turin 10126, Italy.
authors.forename: Alessia
authors.initials: A
authors.lastname: Ciancio
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D005260:Female; D019701:Hepatitis D, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010880:Piperidines / Q000008:administration & dosage* / Q000009:adverse effects*; D011725:Pyridines / Q000008:administration & dosage* / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D010880:Piperidines; D011725:Pyridines